Concepedia

Edward Kay

EK

Statistics

Publications

4

Citations

1.3K

H-Index

4

Active since

1996

Affiliations

Medical Research Council(Current)

Cardiff University

Velindre Cancer Centre

Cancer Trials Ireland

Queen's University Belfast

Edward Kay is an author at Medical Research Council specializing in oxaliplatin-based therapy, colorectal cancer, and combination chemotherapy.

Publications per year

1996–2011

4

Publications

4

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Tim Maughan, Richard Adams, Christopher G. Smith et al. · The Lancet · 2011 · 967 citations

, , +12

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Richard Adams, Angela Meade, Richard H. Wilson et al. · The Lancet Oncology · 2011 · 263 citations · Full text

, , +9

Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience

Richard Adams, Angela Meade, Ayman Madi et al. · British Journal of Cancer · 2009 · 64 citations · Full text

, , +15

Enzymatic debridement for necrotic wounds

Séamus J. Martin, O J Corrado, Edward Kay · Journal of Wound Care · 1996 · 36 citations

, , +17

1–4 of 4